Viewing Protocol Section

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT04599465
Ignite Creation Date: 2024-05-06 @ 3:18 PM
Last Modification Date: 2024-10-26 @ 1:47 PM
Study NCT ID: NCT04599465
Protocol Section: NCT04599465
Start Identification Module Data
Expand Identification Module Data
Brief Title: A Study to Assess the Effect of ELXTEZIVA on Glucose Tolerance in Participants With Cystic Fibrosis CF
Official Title: A Phase 3b Open-label Study to Assess the Effect of Elexacaftor ELXTezacaftor TEZIvacaftor IVA on Glucose Tolerance in Cystic Fibrosis Subjects With Abnormal Glucose Metabolism
Acronym: None
Organization: Vertex Pharmaceuticals Incorporated
Organization Class: INDUSTRY
Organization Study ID: VX19-445-117
Secondary IDs
Secondary ID Type Domain Link
2020-003170-44 EUDRACT_NUMBER None None
Start Status Module Data
Status Verified Date: 2023-07
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Vertex Pharmaceuticals Incorporated
Lead Sponsor Class: INDUSTRY
Lead Sponsor: Vertex Pharmaceuticals Incorporated
Start Oversight Module Data 350564
Description Module: 354064
Study Last Update Post Date Type(Status Module):
Attachment: Upload